Receiver operation characteristic (ROC) curve analysis revealed that serum RCAN2, especially serum RCAN2/(AST/ALT) ratio, might serve as a candidate biomarker for obesity. This evidence concerns the gene RCAN2 and obesity due to melanocortin 4 receptor deficiency.